Economic Evaluations of Influenza Vaccination in Healthy Working-Age Adults: Employer and Society Perspective

Author： Wood S.C.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.18, Iss.2, 2000-08, pp. : 173-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Seasonal Influenza Vaccination of Healthy Working-Age Adults: A Review of Economic Evaluations

By Gatwood Justin  

Drugs, Vol. 72, Iss. 1, 2012-01 ,pp. : 35-48

Adis International

Access to resources Recommend Favorite

Influenza vaccine cost saving in healthy, working-age adults?

By  

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Influenza vaccine cost saving in healthy, working-age adults?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 285, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group

By Newall Anthony T.   Kelly Heath   Harsley Stuart  

PharmacoEconomics, Vol. 27, Iss. 6, 2009-06 ,pp. : 439-450

Adis International

Access to resources Recommend Favorite

Issues in the Economic Evaluation of Influenza Vaccination by Injection of Healthy Working Adults in the US: A Review and Decision Analysis of Ten Published Studies

By Hogan Thomas J.  

PharmacoEconomics, Vol. 30, Iss. 5, 2012-05 ,pp. : 355-371

Adis International

Access to resources Recommend Favorite